USANA Health Sciences Files 2023 10-K Report

TL;DR

**USANA's 2023 10-K is out, confirming fiscal year-end on Dec 30, 2023, but key financial numbers aren't in this snippet.**

AI Summary

USANA HEALTH SCIENCES INC filed its 10-K report on February 27, 2024, for the fiscal year ended December 30, 2023. The filing confirms the company's operations in medicinal chemicals and botanical products. Specific financial performance figures, such as revenue or net income, are not detailed in the provided excerpt. The company's CIK is 0000896264.

Why It Matters

This annual filing provides a comprehensive overview of USANA's financial performance and operational status for the past fiscal year, offering transparency to investors and the public. It's crucial for assessing the company's health and future prospects.

Risk Assessment

Risk Level: medium — Without specific financial performance data (revenue, profit, debt), it's impossible to assess the company's financial risk from this snippet alone.

Key Numbers

• N/A — Revenue (Specific revenue figures are not provided in the excerpt.)
• N/A — Net Income (Specific net income figures are not provided in the excerpt.)
• 2023-12-30 — Fiscal Year End (The period covered by this 10-K filing.)
• 2024-02-27 — Filing Date (Date the 10-K was filed with the SEC.)

Key Players & Entities

• USANA HEALTH SCIENCES INC (company) — filer
• December 30, 2023 (date) — fiscal year end
• February 27, 2024 (date) — filing date
• USANA INC (company) — former name
• Salt Lake City, UT (location) — business address

FAQ

From the Filing

0000896264-24-000093.txt : 20240227 0000896264-24-000093.hdr.sgml : 20240227 20240227162650 ACCESSION NUMBER: 0000896264-24-000093 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 100 CONFORMED PERIOD OF REPORT: 20231230 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 24687257 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-K 1 usna-20231230.htm 10-K usna-20231230 0000896264 FY false 2023 P3Y http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent 0000896264 2023-01-01 2023-12-30 0000896264 2023-07-01 iso4217:USD 0000896264 2024-02-23 xbrli:shares 0000896264 2023-12-30 0000896264 2022-12-31 iso4217:USD xbrli:shares 0000896264 2022-01-02 2022-12-31 0000896264 2021-01-03 2022-01-01 0000896264 us-gaap:CommonStockMember 2021-01-02 0000896264 us-gaap:AdditionalPaidInCapitalMember 2021-01-02 0000896264 us-gaap:RetainedEarningsMember 2021-01-02 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-02 0000896264 2021-01-02 0000896264 us-gaap:RetainedEarningsMember 2021-01-03 2022-01-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-03 2022-01-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2021-01-03 2022-01-01 0000896264 us-gaap:CommonStockMember 2021-01-03 2022-01-01 0000896264 us-gaap:CommonStockMember 2022-01-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2022-01-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 0000896264 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2022-01-02 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-30 0000896264 us-gaap:CommonStockMember 2023-01-01 2023-12-30 0000896264 us-gaap:CommonStockMember 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 usna:region 0000896264 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2023-12-30 0000896264 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2023-12-30 0000896264 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2023-12-30 0000896264 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2023-12-30 0000896264 us-gaap:FairValueMeasurementsRecur